However, patients with osteosarcoma are resistant to PD-1/PD-L1 inhibitors, and anti-PD-1 monotherapy has been ineffective against osteosarcoma in a murine model of K7M2 osteosarcoma grafts [22]. The gene discussed is PDCD1; the disease is osteosarcoma.